<DOC>
	<DOCNO>NCT02767414</DOCNO>
	<brief_summary>The primary purpose study validate sensitivity specificity Respirio Flu Test eLab Flu Test detect Influenza A compare gold standard detection , Reverse Transcriptase Polymerase Chain Reaction ( RT-PCR ) . The secondary aim : Validate sensitivity specificity Respirio Flu Test eLab Flu Test detect Influenza B compare gold standard detection , Reverse Transcriptase Polymerase Chain Reaction ( RT-PCR ) ; Evaluate correct interpretation Respirio Flu Test subject influenza-like symptom ; Evaluate subject ' satisfaction convenience , comfort ease use Respirio Flu Test .</brief_summary>
	<brief_title>Validation Ellume® Respirio Flu Test Ellume® eLab Flu Test Rapid Identification Influenza A/B</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Male female subject age ≥ 1 year ; Rhinorrhea ; ≤ 5 day onset influenzalike illness symptom ; Subject ( parent/legal guardian ) capable willing give inform consent/assent ; Subject ( parent/legal guardian ) able read write English . Has undergone treatment antiviral within previous 7 day ; Has vaccinate mean influenza nasal spray/mist vaccine within previous 7 day ; Recent craniofacial injury surgery , include surgery correct deviation nasal septum , within previous 6 month ; Currently enrol another clinical trial use investigational device within 90 day precede informed consent ; Has prior exposure Respirio Flu Test eLab Flu Test .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>